Search
Search titles only
By:
Search titles only
By:
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
Search
Search titles only
By:
Search titles only
By:
New posts
Search forums
Menu
Install the app
Install
Reply to Thread
Guest, we'd love to know what you think about the forum! Take the
Diabetes Forum Survey 2024 »
Home
Forums
Diabetes Management
Diabetes Medication and Drugs
Other Diabetic Medications
Medical Cannabis
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="JohnEGreen" data-source="post: 1145166" data-attributes="member: 223921"><p>That would be Sativex, It is licenced in the UK for treating MS spasticity.</p><p></p><p>Being prescribed Sativex</p><p></p><p>Sativex can only be prescribed by a specialist doctor with experience of treating MS spasticity - consultant neurologists, consultant rehabilitation specialists and consultant pain specialists.</p><p></p><p>Use of Sativex is currently limited to those people who respond to the first four weeks of treatment. If there is no clear improvement in spasticity-related symptoms, treatment is stopped.</p><p></p><p>Sativex has not been fully assessed by NICE (the National Institute for Health and Care Excellence) as part of a separate technology appraisal. However, in the 2014 MS Clinical Guideline NICE did not recommend prescription of Sativex "because it is not a cost effective treatment".</p><p></p><p>In April 2011, the Scottish Medicines Consortium (SMC), which plays the equivalent role for the NHS in Scotland, announced that it was unable to recommend Sativex as it has not received a marketing authorisation submission from the manufacturer.</p><p></p><p>In August 2014, the All Wales Medicines Strategy Group (AWMSG) recommended that Sativex could be used within the NHS in Wales as a treatment for the symptoms of moderate to severe spasticity in people with MS.</p></blockquote><p></p>
[QUOTE="JohnEGreen, post: 1145166, member: 223921"] That would be Sativex, It is licenced in the UK for treating MS spasticity. Being prescribed Sativex Sativex can only be prescribed by a specialist doctor with experience of treating MS spasticity - consultant neurologists, consultant rehabilitation specialists and consultant pain specialists. Use of Sativex is currently limited to those people who respond to the first four weeks of treatment. If there is no clear improvement in spasticity-related symptoms, treatment is stopped. Sativex has not been fully assessed by NICE (the National Institute for Health and Care Excellence) as part of a separate technology appraisal. However, in the 2014 MS Clinical Guideline NICE did not recommend prescription of Sativex "because it is not a cost effective treatment". In April 2011, the Scottish Medicines Consortium (SMC), which plays the equivalent role for the NHS in Scotland, announced that it was unable to recommend Sativex as it has not received a marketing authorisation submission from the manufacturer. In August 2014, the All Wales Medicines Strategy Group (AWMSG) recommended that Sativex could be used within the NHS in Wales as a treatment for the symptoms of moderate to severe spasticity in people with MS. [/QUOTE]
Verification
Post Reply
Home
Forums
Diabetes Management
Diabetes Medication and Drugs
Other Diabetic Medications
Medical Cannabis
Top
Bottom
Find support, ask questions and share your experiences. Ad free.
Join the community »
This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies.
Accept
Learn More.…